Published Case Reports: A Detailed Review Case 1: Dose Escalation in Metastatic Colon Cancer (2026) A 2026 paper in the World Journal of Clinical Cases (PMC12836008) reports a 47-year-old woman with Lynch syndrome-associated metastatic colon cancer on nivolumab/relatlimab (Opdualag)
tirzepatide Along with possible side effects from retatrutide and tirzepatide, rapid weight loss can cause other problems
Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation
They improve vascular function, promote sodium excretion, and support heart health
A pilot trial suggested metformin might reduce cognitive decline in people without diabetes, and a large-scale dementia prevention trial with metformin has been proposed in people without diabetes [49,50,51]
Low socioeconomic status may be a strong reason for malnourishment due to financial constraints